Fragile X syndrome IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Fragile X syndrome IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 196382. The device is manufactured by Asuragen, Inc. from United States, classified as In Vitro Diagnostic Device.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

Fragile X syndrome IVD, kit, nucleic acid technique (NAT)

MHRA Device ID: 196382

Device Type

In Vitro Diagnostic Device

Type

Class C

Status

DREGIY

Date Registered

Jul 4, 2024

Manufacturer Information

Name

Asuragen, Inc.

Address

2150 Woodward Street, Suite 100

Austin, Texas, United States

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from Asuragen, Inc. (9)

Fragile X syndrome IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Device Type

Type

Status

Date Registered

Name

Address

DJ Fang

Alpha-fetoprotein (AFP) IVD, kit, fluorescent immunoassay

Cyclic citrullinated peptide antibody (anti-CCP) IVD, kit, fluorescent immunoassay

Streptococcus pneumoniae antigen IVD, kit, rapid ICT, clinical

Allergen-specific/total immunoglobulin E (IgE) antibody IVD, kit, fluorescent immunoassay

C-reactive protein (CRP) IVD, kit, fluorescent immunoassay

Cryptosporidium species antigen IVD, kit, rapid ICT, clinical

Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

Trichomonas vaginalis antigen IVD, kit, rapid ICT, clinical

D-dimer IVD, kit, fluorescent immunoassay

General specimen container IVD, additive/medium

Myotonic dystrophy IVD, kit, nucleic acid technique (NAT)

Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)

Huntington's disease IVD, kit, nucleic acid technique (NAT)

Philadelphia chromosome/BCR-ABL mRNA expression IVD, kit, nucleic acid technique (NAT)

Spinal muscular atrophy (SMA) IVD, kit, nucleic acid technique (NAT)

Fragile X syndrome IVD, kit, nucleic acid technique (NAT)

Human genomic analysis interpretive software IVD

Philadelphia chromosome/BCR-ABL mRNA expression IVD, kit, nucleic acid technique (NAT)